Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trial

https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(24)00456-3/abstract?utm_campaign=update-laneur&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_laneur&_hsenc=p2ANqtz--z2GsJF1Pv7lYOWCACEqJneoSL8CrNXJVZi9d6HlQiJUgMKKAiV0HwpJoXZLYRb-p-92T2eWmoj786D8dZYdiRuI8gPw&_hsmi=345671372&utm_content=345613733&utm_source=hs_email